Update on the treatment of calcinosis in dermatomyositis

被引:4
|
作者
Shinjo, Samuel Katsuyuki [1 ]
Carlos de Souza, Fernando Henrique [1 ]
机构
[1] Univ Sao Paulo HC FMUSP, Sch Med, Hosp Clin, Serv Rheurnatol, Sao Paulo, Brazil
关键词
Review; Calcinosis; Dermatomyositis; Therapy; JUVENILE DERMATOMYOSITIS; CHILDHOOD DERMATOMYOSITIS; THERAPY; UNIVERSALIS; DILTIAZEM; MANAGEMENT; RESOLUTION; CALCIFICATIONS; HYPERCALCEMIA; INFLAMMATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcinosis is a connective tissue disorder classified into the following four types: metastatic; idiopathic; iatrogenic and dystrophic. Dystrophic calcinosis can occur, for example, in dermatomyositis, mainly in juvenile dermatomyositis, and is characterized by an abnormal deposition of calcium salts in affected skin, subcutaneous tissues, and muscles or tendons, with normal serum levels of calcium and phosphate. The treatment of calcinosis in dermatomyositis remains a challenge, with few descriptions in the literature of low scientific evidence. So far, no therapy has proved to be highly effective in the combat and resolution of that comorbidity. The present study discusses the concept of calcinosis, particularly in dermatomyositis, as well as its treatment described in the literature. (C) 2013 Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:211 / 214
页数:4
相关论文
共 50 条
  • [31] Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy
    Mori, Hiroko
    Okada, Yosuke
    Yamaoka, Kunihiro
    Saito, Kazuyoshi
    Tanaka, Yoshiya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (01) : 114 - 118
  • [32] Calcinosis in Adult-Onset Dermatomyositis: Metastatic or Dystrophic?
    Barry Ladizinski
    Ali Khan
    Christopher Sankey
    Journal of General Internal Medicine, 2014, 29 : 246 - 247
  • [33] Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis?
    Valenzuela, Antonia
    Chung, Lorinda
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (01) : 7 - 23
  • [34] Treatment of Achilles tendon calcinosis in juvenile dermatomyositis with external ilizarov fixator
    Bilavsky, E.
    Horesh, Z.
    Amir, J.
    Bar-On, E.
    Harel, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (05) : 763 - 765
  • [35] Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment options
    Fredi, M.
    Bartoli, F.
    Cavazzana, I.
    Ceribelli, A.
    Carabellese, N.
    Tincani, A.
    Satoh, M.
    Franceschini, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (02) : 303 - 308
  • [36] Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
    Orandi, Amir B.
    Dharnidharka, Vikas R.
    Al-Hammadi, Noor
    Baszis, Kevin W.
    PEDIATRIC RHEUMATOLOGY, 2018, 16
  • [37] Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
    Amir B. Orandi
    Vikas R. Dharnidharka
    Noor Al-Hammadi
    Kevin W. Baszis
    Pediatric Rheumatology, 16
  • [38] Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications
    Harel, L
    Harel, G
    Korenreich, L
    Straussberg, R
    Amir, J
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (05) : 1129 - 1132
  • [39] Treatment of subcutaneous calcinosis in systemic disorders
    Bienvenu, B.
    REVUE DE MEDECINE INTERNE, 2014, 35 (07): : 444 - 452
  • [40] Update on dermatomyositis
    Tanboon, Jantima
    Nishino, Ichizo
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (05) : 611 - 621